293 related articles for article (PubMed ID: 26618756)
1. The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
Bahouth Z; Halachmi S; Moskovitz B; Nativ O
Expert Rev Anticancer Ther; 2016; 16(2):189-98. PubMed ID: 26618756
[TBL] [Abstract][Full Text] [Related]
2. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
[TBL] [Abstract][Full Text] [Related]
3. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.
Lammers RJ; Witjes JA; Inman BA; Leibovitch I; Laufer M; Nativ O; Colombo R
Eur Urol; 2011 Jul; 60(1):81-93. PubMed ID: 21531502
[TBL] [Abstract][Full Text] [Related]
4. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency-induced thermo-chemotherapy effect (RITE) for non muscle invasive bladder cancer treatment: current role and perspectives.
Colombo R; van Valenberg H; Moschini M; Witjes JA
Urologia; 2016 Oct; 83(Suppl 2):7-17. PubMed ID: 27768213
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.
Tan WS; Panchal A; Buckley L; Devall AJ; Loubière LS; Pope AM; Feneley MR; Cresswell J; Issa R; Mostafid H; Madaan S; Bhatt R; McGrath J; Sangar V; Griffiths TRL; Page T; Hodgson D; Datta SN; Billingham LJ; Kelly JD
Eur Urol; 2019 Jan; 75(1):63-71. PubMed ID: 30274699
[TBL] [Abstract][Full Text] [Related]
7. [Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.].
Coenen JJMJH; van Valenberg FJP; Arends TJH; Witjes JA
Arch Esp Urol; 2018 May; 71(4):400-408. PubMed ID: 29745929
[TBL] [Abstract][Full Text] [Related]
8. Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
Ba M; Cui S; Wang B; Long H; Yan Z; Wang S; Wu Y; Gong Y
Oncol Rep; 2017 May; 37(5):2761-2770. PubMed ID: 28405683
[TBL] [Abstract][Full Text] [Related]
9. Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression.
Maffezzini M; Campodonico F; Canepa G; Manuputty EE; Tamagno S; Puntoni M
Cancer Chemother Pharmacol; 2014 May; 73(5):925-30. PubMed ID: 24585046
[TBL] [Abstract][Full Text] [Related]
10. BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301).
Hayne D; Stockler M; McCombie SP; Chalasani V; Long A; Martin A; Sengupta S; Davis ID
BMC Cancer; 2015 May; 15():432. PubMed ID: 26014129
[TBL] [Abstract][Full Text] [Related]
11. Analysis of tolerance and security of chemo hyperthermia with Mitomycin C for the treatment of non-muscle invasive bladder cancer.
León-Mata J; Domínguez JL; Redorta JP; Sousa González D; Alvarez Casal M; Sousa Escandón A; Piñeiro Vázquez E
Arch Esp Urol; 2018 May; 71(4):426-437. PubMed ID: 29745932
[TBL] [Abstract][Full Text] [Related]
12. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer.
van Valenberg H; Colombo R; Witjes F
Int J Hyperthermia; 2016 Jun; 32(4):351-62. PubMed ID: 26905963
[TBL] [Abstract][Full Text] [Related]
13. Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer.
Sousa A; Piñeiro I; Rodríguez S; Aparici V; Monserrat V; Neira P; Carro E; Murias C; Uribarri C
Int J Hyperthermia; 2016 Jun; 32(4):374-80. PubMed ID: 26915466
[TBL] [Abstract][Full Text] [Related]
14. Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer.
Gözen AS; Umari P; Scheitlin W; Su FE; Akin Y; Rassweiler J
Arch Ital Urol Androl; 2017 Jun; 89(2):102-105. PubMed ID: 28679178
[TBL] [Abstract][Full Text] [Related]
15. [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
Irani J
Prog Urol; 2016 Nov; 26(14):860-864. PubMed ID: 27712914
[TBL] [Abstract][Full Text] [Related]
16. Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)-Does it complicate surgery and adversely impact oncological outcome?
Sri D; Lee HJ; El-Gemmal S; Backhouse C; Tay A; John B; Perry MJ; Ayres BE; Issa R
Urol Oncol; 2021 May; 39(5):300.e15-300.e20. PubMed ID: 33032922
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage.
Grimberg DC; Dudinec J; Shah A; Inman BA
Urol Oncol; 2021 Aug; 39(8):498.e13-498.e20. PubMed ID: 33485761
[TBL] [Abstract][Full Text] [Related]
18. Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study.
Geijsen ED; de Reijke TM; Koning CC; Zum Vörde Sive Vörding PJ; de la Rosette JJ; Rasch CR; van Os RM; Crezee J
J Urol; 2015 Nov; 194(5):1202-8. PubMed ID: 26143111
[TBL] [Abstract][Full Text] [Related]
19. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations.
Liem EI; Crezee H; de la Rosette JJ; de Reijke TM
Int J Hyperthermia; 2016 Jun; 32(4):363-73. PubMed ID: 27056069
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC).
Colombo R; Salonia A; Leib Z; Pavone-Macaluso M; Engelstein D
BJU Int; 2011 Mar; 107(6):912-8. PubMed ID: 21029314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
